viewTertiary Minerals PLC

Tertiary Minerals says no reason for share price surge aside from recent MoU with Possehl

Tertiary Minerals said negotiations with Possehl about an offtake agreement are ongoing but there can be no guarantee of a deal

Tertiary Minerals
Possehl would take at least 70% of commercial grade acid-spar produced in Sweden, Norway, and in Nevada

Tertiary Minerals plc (LON:TYM), which saw its shares surge higher on Friday, said after the close that it was not aware of any other reason for the movement other than the recently announced memorandum of understanding (MoU) signed with global commodities group Possehl.

The MoU provides for the companies to enter into an offtake agreement to support Tertiary’s three fluorspar projects.

READ: Tertiary Minerals rejuvenates fluorspar operation through tie-up with Possehl

However, the group said on Friday a definitive offtake agreement is subject to further negotiation with Possehl, and the detailed commercial terms have yet to be agreed.

“There can be no guarantee that an offtake agreement will be entered into,” Tertiary Minerals said.

Under the offtake agreement, Possehl would take at least 70% of commercial grade acid-spar produced at Storuman in Sweden; Lassedalen in Norway; and MB in Nevada.

Possehl, which is part of commodities business Cremer, would provide funds to develop the deposits and for any acquisitions Tertiary may make to bulk them up.

Tertiary would also receive logistics and infrastructure support from the German-based group while the projects are developed.

The MoU will be effective until one of Tertiary’s projects has been in production for a year or a formal offtake agreement is signed.

Quick facts: Tertiary Minerals PLC

Price: 0.212 GBX

Market: AIM
Market Cap: £1.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Sareum Holdings raises over a £1mln to advance preclinical work on its...

Sareum Holdings PLC's (LON:SAR) Tim Mitchell caught up with Proactive London's Andrew Scott following the news it's raised just over £1mln to advance the preclinincal work on its TYK2/JAK1 drugs SDC-1801 and SDC-1802. Mitchell says they're exploring the potential benefit of the TYK2/JAK1...

55 minutes ago

2 min read